Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
bezlotoxumab (zinplava) (1 trial)
daptomycin (cubicin) (1 trial)
sodium chloride (1 trial)
vancomycin (Vancocin) (1 trial)
Clostridium Infections (Phase 2)
Communicable Diseases (Phase 2)
Infections (Phase 2)
Soft Tissue Infections (Phase 2)
Trials (2 total)
Trial APIs (4 total)